Geode Capital Management’s NeueHealth NEUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-35,415
Closed -$236K 4570
2025
Q3
$236K Buy
35,415
+455
+1% +$3.06K ﹤0.01% 3869
2025
Q2
$241K Buy
34,960
+24
+0.1% +$161 ﹤0.01% 3812
2025
Q1
$236K Buy
34,936
+1,489
+4% +$10.4K ﹤0.01% 3785
2024
Q4
$248K Hold
33,447
﹤0.01% 3826
2024
Q3
$175K Buy
33,447
+971
+3% +$5.14K ﹤0.01% 3945
2024
Q2
$177K Buy
32,476
+2,245
+7% +$13.4K ﹤0.01% 3957
2024
Q1
$197K Buy
30,231
+519
+2% +$4.63K ﹤0.01% 3945
2023
Q4
$227K Hold
29,712
﹤0.01% 3895
2023
Q3
$177K Buy
29,712
+1,524
+5% +$15.7K ﹤0.01% 4030
2023
Q2
$344K Sell
28,188
-22,574
-44% -$299K ﹤0.01% 3791
2023
Q1
$895K Buy
50,762
+1,412
+3% +$72.8K ﹤0.01% 3398
2022
Q4
$2.56M Buy
49,350
+911
+2% +$66.2K ﹤0.01% 2947
2022
Q3
$4.07M Buy
48,439
+28,164
+139% +$3.74M ﹤0.01% 2778
2022
Q2
$2.95M Sell
20,275
-2,418
-11% -$352K ﹤0.01% 2973
2022
Q1
$3.5M Buy
22,693
+17,556
+342% +$3.9M ﹤0.01% 2983
2021
Q4
$1.41M Buy
5,137
+47
+0.9% +$21.7K ﹤0.01% 3549
2021
Q3
$3.32M Buy
+5,090
New +$4.48M ﹤0.01% 3144

Geode Capital Management's NEUE Position: Q4 2025 in Review

Geode Capital Management sold out of NeueHealth (NEUE) in Q4 2025, closing a stake of 35,415 shares — an estimated $236K sold.

Geode Capital Management first reported a position in NEUE in Q3 2021 and held it in 17 quarters. The position peaked at $4.07M in Q3 2022. 0 funds tracked by Wall St. Rank hold NEUE as of Q4 2025.

  • Geode Capital Management reported no remaining NeueHealth position as of Q4 2025 after selling out during the quarter.
  • Geode Capital Management sold 35,415 NeueHealth shares in Q4 2025, an estimated $236K.
  • Geode Capital Management first reported a position in NeueHealth in Q3 2021 and held it in 17 quarters.
  • Geode Capital Management's NeueHealth position peaked at $4.07M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held NeueHealth as of Q4 2025.

Based on Geode Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.